VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Ventripoint Enters Collaboration Agreement To Test Echocardi

<< Previous

Bullboard Posts

Next >>

Comment by snuff133on Jan 11, 2021 11:10am

153 Views

Post# 32266847

RE:RE:RE:Ventripoint Enters Collaboration Agreement To Test Echocardi

With the current restrictions in the hospitals and covid overwhelming them , I believe this is a very smart avenue to explore and get more sales faster . There's no regulatory hurdles so sales could be imminent if test results are good . Pets are apart and peoples family's and they will spend whatever it takes to keep them healthy. Great job George !!

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)